Tejara Capital LTD Cardiol Therapeutics Inc. Transaction History
Tejara Capital LTD
- $153 Billion
- Q4 2024
A detailed history of Tejara Capital LTD transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 3,115,437 shares of CRDL stock, worth $4.08 Million. This represents 2.61% of its overall portfolio holdings.
Number of Shares
3,115,437
Previous 1,771,270
75.89%
Holding current value
$4.08 Million
Previous $3.51 Billion
13.7%
% of portfolio
2.61%
Previous 1.67%
Shares
8 transactions
Others Institutions Holding CRDL
# of Institutions
46Shares Held
7.58MCall Options Held
4.9KPut Options Held
3.8K-
Advisor Shares Investments LLC Bethesda, MD882KShares$1.16 Million0.23% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$1.04 Million0.31% of portfolio
-
Pvg Asset Management Corp Golden, CO487KShares$638,3563.54% of portfolio
-
Cambridge Investment Research Advisors, Inc.331KShares$432,9610.0% of portfolio
-
Envestnet Asset Management Inc310KShares$405,6860.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $81.1M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...